연구동향 분석

Cost-Effectiveness of Drug-Eluting vs. Bare-Metal Stents in Patients with Coronary Artery Disease from the Korean National Health Insurance Database

이수진 전기홍 백경원 2014년

논문상세정보
인용/피인용
' Cost-Effectiveness of Drug-Eluting vs. Bare-Metal Stents in Patients with Coronary Artery Disease from the Korean National Health Insurance Database' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • bare-metalstents
  • drug-elutingstents
  • incrementalcosteffectivenessratio
  • stentimplantation
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,593 0

0.0%

' Cost-Effectiveness of Drug-Eluting vs. Bare-Metal Stents in Patients with Coronary Artery Disease from the Korean National Health Insurance Database' 의 참고문헌

  • 관상동맥 스텐트 시술 후 제 3차 재협착 예측인자
    조정선 대한내과학회지 69 3 255-263 [2005]
  • Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial
    Morice MC JAMA 295 895-904 [2006]
  • Predictive factors for the second restenosis after coronary interventions
    Jeong MH Catheter Cardiovasc Interv 50 34-39 [2000]
  • Payment system reform for health care providers in Korea
    Kwon S Health Policy Plan 18 84-92 [2003]
  • One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the RAVEL trial
    van Hout BA Heart 91 507-512 [2005]
  • New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality
    Sundararajan V J Clin Epidemiol 57 1288-1294 [2004]
  • Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET)
    Kaiser C Lancet 366 921-929 [2005]
  • Effects of the DRG-based prospective payment system operated by the voluntarily participating providers on the cesarean section rates in Korea
    Lee K HEALTH POLICY 81 300-308 [2007]
  • EXCELLA First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions
    Costa JR Jr EuroIntervention 4 53-58 [2008]
  • Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial
    Cohen DJ Circulation 110 509-514 [2004]
  • Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitäts Trial (BASKET): an 18-month analysis
    Brunner-La Rocca HP Lancet 370 1552-1559 [2007]
  • Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial
    Bakhai A J Am Coll Cardiol 48 253-261 [2006]
  • Coronary in-stent restenosis-predictors, treatment and prevention
    Hoffmann R Eur Heart J 21 1739-1749 [2000]
  • Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction
    Stone GW N Engl J Med 346 957-966 [2002]
  • A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators
    Fischman DL N Engl J Med 331 496-501 [1994]
  • A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
    Charlson ME J Chronic Dis 40 373-383 [1987]
  • A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents
    Babapulle MN Lancet 364 583-591 [2004]
  • A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group
    Serruys PW N Engl J Med 331 489-495 [1994]